XML 124 R95.htm IDEA: XBRL DOCUMENT
v3.20.4

Stockholders' Equity / (Deficit) (Tables) (FaceBank Group, Inc. Pre-Merger) | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 31, 2020 | Sep. 30, 2020 | Dec. 31, 2019
Schedule of Stock Option Activity |  | A summary of activity under the Plan for the nine months ended September 30, 2020 is as follows (in thousands, except share and per share amounts):
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in years) |
Outstanding as of December 31, 2019 |  |  | 16,667 |  |  | $ | 28.20 |  |  | $ | - |  |  |  | 7.3 |
Options assumed from Merger |  |  | 8,051,098 |  |  | $ | 1.31 |  |  |  |  |  |  |  |  |
Granted |  |  | 7,141,899 |  |  | $ | 8.79 |  |  |  |  |  |  |  |  |
Exercised |  |  | (226,740 | ) |  | $ | 1.43 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (389,008 | ) |  | $ | 0.83 |  |  |  |  |  |  |  |  |
Outstanding as of September 30, 2020 |  |  | 14,593,916 |  |  | $ | 4.99 |  |  | $ | 61,234 |  |  |  | 8.2 |
Options vested and exercisable as of September 30, 2020 |  |  | 6,081,567 |  |  | $ | 2.01 |  |  | $ | 42,736 |  |  |  | 6.9 |
Summary of Fair Value of Options Granted |  | The following was used in determining the fair value of stock options granted during the three months and nine months ended September 30, 2020:
|  | For the Three Months Ended September 30, 2020 |  |  | For the Nine Months Ended September 30, 2020 |
Dividend yield |  |  | - |  |  |  | - |
Expected price volatility |  |  | 45 | % |  |  | 45% - 57 | %
Risk free interest rate |  |  | 0.23% - 0.38 | % |  |  | 0.23% - 0.58 | %
Expected term |  |  | 5.3 - 6.1 |  |  |  | 5.3 - 6.1 |
Summary of Outstanding Warrants Activity |  | A summary of the Company’s outstanding warrants as of September 30, 2020 are presented below (in thousands, except share and per share amounts):
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in years) |
Outstanding as of December 31, 2019 |  |  | 200,007 |  |  | $ | 13.31 |  |  | $ | - |  |  |  | 0.2 |
Issued |  |  | 9,538,526 |  |  | $ | 6.62 |  |  | $ | 23,119 |  |  |  | 1.7 |
Expired |  |  | (200,000 | ) |  | $ | - |  |  | $ | - |  |  |  | - |
Outstanding as of September 30, 2020 |  |  | 9,538,533 |  |  | $ | 5.80 |  |  | $ | 32,670 |  |  |  | 2.6 |
Warrants exercisable as of September 30, 2020 |  |  | 9,538,533 |  |  | $ | 5.80 |  |  | $ | 32,670 |  |  |  | 2.6 |
FaceBank Group, Inc Pre-Merger [Member] |  |  |
Schedule of Stock Option Activity | The following reflects the stock option activity for the three months ended March 31, 2020:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in years) |
Outstanding as of December 31, 2019 |  |  | 16,667 |  |  | $ | 28.20 |  |  | $ | - |  |  |  | 8.1 |
Granted |  |  | 280,000 |  |  | $ | 7.20 |  |  | $ | 322,000 |  |  |  | 4.7 |
Outstanding as of March 31, 2020 |  |  | 296,667 |  |  | $ | 8.38 |  |  | $ | 322,000 |  |  |  | 4.9 |
Options vested and exercisable as of March 31, 2020 |  |  | 296,667 |  |  | $ | 8.38 |  |  | $ | 322,000 |  |  |  | 4.9 |
Summary of Fair Value of Options Granted |  |  | The fair value of options granted during the year ended December 31, 2018 were estimated using the following weighted-average assumptions:
|  | Year ended December 31, 2018 |
Exercise price |  | $ | 28.20 |
Expected stock price volatility |  |  | 222 |
Risk-free rate of interest |  |  | 2.78 |
Term (years) |  |  | 10.0 |
Summary of Options Under Employee Stock Option Plan |  |  | A summary of option activity under the Company’s employee stock option plan for years ended December 31, 2018 and 2019 are presented below:
|  |  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in years) |
Outstanding as of December 31, 2017 |  |  |  | - |  |  | $ | - |  |  | $ | - |  |  |  | - |
Granted |  |  |  | 16,667 |  |  |  | 28.20 |  |  |  | - |  |  |  | 9.1 |
Outstanding as of December 31, 2018 |  |  |  | 16,667 |  |  | $ | 28.20 |  |  | $ | - |  |  |  | 9.1 |
Outstanding as of December 31, 2019 |  |  |  | 16,667 |  |  | $ | 28.20 |  |  | $ | - |  |  |  | 8.1 |
Options vested and exercisable as of December 31, 2019 |  |  |  | 16,667 |  |  | $ | 28.20 |  |  | $ | - |  |  |  | 8.1 |
Summary of Outstanding Warrants Activity | A summary of the Company’s outstanding warrants as of March 31, 2020 are presented below:
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |
Outstanding as of December 31, 2019 |  |  | 200,007 |  |  | $ | 12.15 |  |  | $ | - |
Issued |  |  | 3,411,349 |  |  | $ | 5.11 |  |  | $ | 11,038,616 |
Expired |  |  | (200,000 | ) |  | $ | - |  |  | $ | - |
Outstanding as of March 31, 2020 |  |  | 3,411,356 |  |  | $ | 5.16 |  |  | $ | 11,038,616 |
Warrants exercisable as of March 31, 2020 |  |  | 3,411,356 |  |  | $ | 5.16 |  |  | $ | 11,038,616 |
|  | A summary of the Company’s outstanding warrants as of December 31, 2019 and 2018 are presented below:
|  |  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Total Intrinsic Value |  |  | Weighted Average Remaining Contractual Life (in years) |
Outstanding as of December 31, 2017 |  |  |  | 3,015 |  |  | $ | 15.00 |  |  | $ | - |  |  |  | 4.7 |
Exercised |  |  |  | (3,008 | ) |  |  | 15.00 |  |  |  |  |  |  |  | - |
Outstanding as of December 31, 2018** |  |  |  | 7 |  |  | $ | 24,000.00 |  |  | $ | - |  |  |  | 2.9 |
Issued |  |  |  | 200,000 |  |  |  | 11.31 |  |  |  | - |  |  |  | 0.2 |
Outstanding as of December 31, 2019 |  |  |  | 200,007 |  |  | $ | 12.15 |  |  | $ | - |  |  |  | 0.2 |
Warrants exercisable as of December 31, 2019 |  |  |  | 200,007 |  |  | $ | 12.15 |  |  | $ | - |  |  |  | 0.2 |
** The warrants outstanding as of December 31, 2018 had an original exercise price of $0.80. In January 2017, the Company executed a 1-for-10,000 reverse split, that resulted in an exercise price of $800. Following the 1 for 30 reverse split in February 2019, the exercise price is currently $24,000 per share.

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=FUBO_FaceBankGroupIncPreMergerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |